NuTide 302: A phase IB study to assess the safety, pharmacokinetics and clinical activity of NUC-3373 in combination with standard agents used in colorectal cancer treatment.

American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(36), p. TPS3617-TPS3617

Journal article published in 2018 by Sarah Patricia Blagden, T. R. Jeffry Evans, Essam Ahmed Ghazaly

, Chathunissa Gnanaranjan, Aimery De Gramont, Josep Tabernero, Jordan Berlin

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by